Editorial: spp.-transmission, pathogenesis, host-pathogen interaction, prevention and treatment.
作者信息
Buroni Silvia, Samy Ramar Perumal
机构信息
Department of Biology and Biotechnology "Lazzaro Spallanzani", University of Pavia, Pavia, Italy.
Department of Anatomy, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
出版信息
Front Microbiol. 2023 Jun 6;14:1226865. doi: 10.3389/fmicb.2023.1226865. eCollection 2023.
Abstract
摘要
相似文献
1
Editorial: spp.-transmission, pathogenesis, host-pathogen interaction, prevention and treatment.
Front Microbiol. 2023 Jun 6;14:1226865. doi: 10.3389/fmicb.2023.1226865. eCollection 2023.
2
Editorial: spp. - Transmission, pathogenesis, host-pathogen interaction, prevention and treatment.
Front Microbiol. 2023 Oct 19;14:1307723. doi: 10.3389/fmicb.2023.1307723. eCollection 2023.
3
Editorial: spp. -transmission, pathogenesis, host-pathogen interaction, prevention and treatment.
Front Microbiol. 2024 May 16;15:1411790. doi: 10.3389/fmicb.2024.1411790. eCollection 2024.
4
Editorial: spp.-transmission, pathogenesis, host-pathogen interaction, prevention and treatment.
Front Microbiol. 2023 Nov 2;14:1320343. doi: 10.3389/fmicb.2023.1320343. eCollection 2023.
5
Editorial: spp.-transmission, pathogenesis, host-pathogen interaction, prevention, and treatment.
Front Microbiol. 2023 Aug 2;14:1258837. doi: 10.3389/fmicb.2023.1258837. eCollection 2023.
6
Mechanisms of Disease: Host-Pathogen Interactions between Burkholderia Species and Lung Epithelial Cells.
Front Cell Infect Microbiol. 2015 Nov 18;5:80. doi: 10.3389/fcimb.2015.00080. eCollection 2015.
7
A reverse-phase protein microarray-based screen identifies host signaling dynamics upon Burkholderia spp. infection.
Front Microbiol. 2015 Jul 27;6:683. doi: 10.3389/fmicb.2015.00683. eCollection 2015.
8
An Overview of the Treatment of Less Common Non-Lactose-Fermenting Gram-Negative Bacteria.
Pharmacotherapy. 2020 Sep;40(9):936-951. doi: 10.1002/phar.2447. Epub 2020 Aug 14.
9
Burkholderia cepacia septicemia in a pediatric oncology patient: a pharmacotherapy challenge.
Ann Pharmacother. 2012 Jun;46(6):e16. doi: 10.1345/aph.1R015. Epub 2012 May 8.
10
In silico prediction of host-pathogen protein interactions in melioidosis pathogen Burkholderia pseudomallei and human reveals novel virulence factors and their targets.
Brief Bioinform. 2021 May 20;22(3). doi: 10.1093/bib/bbz162.
本文引用的文献
1
Compilation of the Antimicrobial Compounds Produced by Sensu Stricto.
Molecules. 2023 Feb 8;28(4):1646. doi: 10.3390/molecules28041646.
2
Melioidosis in South Asia (India, Nepal, Pakistan, Bhutan and Afghanistan).
Trop Med Infect Dis. 2018 May 22;3(2):51. doi: 10.3390/tropicalmed3020051.
3
Infections in Cystic Fibrosis Patients: Drug Resistance and Therapeutic Approaches.
Front Microbiol. 2017 Aug 22;8:1592. doi: 10.3389/fmicb.2017.01592. eCollection 2017.
4
Antibiotic resistance in Burkholderia species.
Drug Resist Updat. 2016 Sep;28:82-90. doi: 10.1016/j.drup.2016.07.003. Epub 2016 Jul 30.
5
Cell Wall Recycling-Linked Coregulation of AmpC and PenB β-Lactamases through ampD Mutations in Burkholderia cenocepacia.
Antimicrob Agents Chemother. 2015 Dec;59(12):7602-10. doi: 10.1128/AAC.01068-15. Epub 2015 Sep 28.
6
Association of melioidosis incidence with rainfall and humidity, Singapore, 2003-2012.
Emerg Infect Dis. 2015 Jan;21(1):159-62. doi: 10.3201/eid2101.140042.
7
Emerging clinico-epidemiological trends in melioidosis: analysis of 95 cases from western coastal India.
Int J Infect Dis. 2012 Jul;16(7):e491-7. doi: 10.1016/j.ijid.2012.02.012. Epub 2012 Apr 16.
8
Deciphering the role of RND efflux transporters in Burkholderia cenocepacia.
PLoS One. 2011 Apr 19;6(4):e18902. doi: 10.1371/journal.pone.0018902.
9
Exploring the HME and HAE1 efflux systems in the genus Burkholderia.
BMC Evol Biol. 2010 Jun 3;10:164. doi: 10.1186/1471-2148-10-164.
10
Burkholderia cepacia complex bacteria: opportunistic pathogens with important natural biology.
J Appl Microbiol. 2008 Jun;104(6):1539-51. doi: 10.1111/j.1365-2672.2007.03706.x. Epub 2008 Jan 24.
Zotero 插件